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Abstract   
Developmental exposure to the endocrine-active compound bisphenol A (BPA) has been linked 
to epigenotoxic and potential carcinogenic effects in rodent liver, prostate, and mammary glands. 
We previously reported a dose-dependent increase in hepatic tumors in 10-month mice 
perinatally exposed to one of three doses of BPA (50 ng, 50 µg, or 50 mg BPA/kg chow). These 
tumors represent early-onset disease and lack classical sexual dimorphism in incidence. Here, we 
investigate adult epigenome-wide liver DNA methylation profiles to identify gene promoters 
associated with perinatal BPA exposure and disease in 10-month mice with and without liver 
tumors. Mice with hepatic tumors showed 12,822 (1.8%) probes with differential methylation as 
compared to non-tumor animals, of which 8,656 (67.5%) were hypomethylated. We observed a 
significant enrichment of differential methylation in Gene Ontology (GO) terms and biological 
processes related to morphogenesis and development, and epigenomic alteration. Pathway 
enrichment revealed a predominance of hypermethylated neuronal signaling pathways linked to 
energy regulation and metabolic function, supporting metabolic consequences in the liver via 
BPA-induced disruption of neuronal signaling pathways. Hypothesis-driven pathway analysis 
revealed mouse and human genes linked to BPA exposure related to intracellular Jak/STAT and 
MAPK signaling pathways. Taken together, these findings are indicators of the relevance of the 
hepatic tumor phenotype seen in BPA-exposed mice to human health. This work demonstrates 
that epigenome-wide discovery experiments in animal models are effective tools for 
identification and understanding of paralagous epimutations salient to human disease. 
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Bisphenol A (BPA) is a high production volume monomer used in the manufacture of 
polycarbonate plastics and other consumer products that has been implicated as an endocrine 
disruptor, due to its ability to bind both canonical and non-canonical estrogen receptors 
(Welshons, et al., 2006). Biomonitoring studies routinely detect levels of BPA in urine in > 90% 
of adults in the United States, indicating that exposure to BPA is widespread (Calafat et al., 
2008).  Environmental BPA exposure is associated with several health outcomes in rodents and 
humans, including impaired fertility, altered immune and thyroid function, and increased risk for 
obesity, diabetes, and cardiovascular disease (Rochester, 2013). Furthermore, BPA has been 
implicated as a potential carcinogen when administered in early life, due to its association with 
proliferative tissue changes in rat mammary glands (Acevedo et al., 2013) and rat prostate glands 
(Ho et al., 2006) and with frank prostate cancer in mice with human prostate stem cell xenografts 
supplemented with sex steroid hormones to mimic human male aging (Prins et al., 2014).  
Previously, we reported a dose-dependent increase in hepatic tumors, or combined 
incidence of hepatocellular carcinomas and hepatic adenomas, in 10-month mice perinatally 
exposed to one of three doses of BPA in the diet (Weinhouse et al., 2014). In contrast, no 
statistically significant relationship between liver tumors and BPA exposure in adult rodents was 
seen in the 1982 regulatory evaluation of BPA’s carcinogenicity, which employed doses 200-
20,000 times higher than those used in our study, supporting the importance of exposure timing 
(NTP 1982). The liver tumors we observed were evident at 10-months of age (Weinhouse et al., 
2014), which represents early onset disease in mice, and the tumors did not exhibit the classical 
sexual dimorphism in incidence Male rodents and humans are two to four times as likely as 
females to present with hepatocellular carcinoma, a ratio that is largely accepted to result from 
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the protective, anti-inflammatory effect of endogenous estrogen in females (Shi et al., 2014).  We 
observed only a proliferative response in exposed animals with hepatic tumors, with no evidence 
of fibrosis or necrosis, indicating that cellular proliferation was likely a primary response to 
BPA, rather than a secondary, regenerative response to chemical-induced tissue injury 
(Weinhouse et al., 2014).  
 Studies of early life exposure to exogenous chemicals, including BPA, are increasingly 
focused on the epigenome as a potential mechanism for persistence of exposure effects across the 
life course (Singh and Li, 2012). The epigenome, or genome-wide collection of epigenetic marks 
that govern gene expression, may be particularly vulnerable to disruption during embryogenesis 
(Jirtle and Skinner, 2007). In addition, alterations that occur during this critical developmental 
window may persist into adulthood, influencing adult health outcomes (Jirtle and Skinner, 2007). 
Perinatal exposure to BPA has previously been shown to alter tail DNA methylation at the coat-
color linked A
vy 
(viable yellow Agouti) metastable epiallele (Anderson et al., 2012a; Dolinoy et 
al., 2007) in weanling mice. Several other studies have identified epigenetic alterations at 
specific genes linked to BPA dose and tissue alterations (Avissar-Whiting et al., 2010; 
Greathouse et al., 2012; Weinhouse et al., 2015), supporting the hypothesis that epigenetic 
changes may mediate the relationship between early life BPA exposure and adult health 
outcomes. In particular, BPA exposure has been linked to epigenetic dysregulation of estrogen-
associated target genes, including nuclear estrogen receptors in rats (Doshi et al., 2011) and 
developmental transcription factor Hoxa10 in mice and human mammary carcinoma cells 
(Bromer et al., 2010). Global epigenomic regulators are altered by BPA exposure, as well, 
including histone methyltransferase Ezh2 (Doherty et al., 2010), maintenance DNA 
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methyltransferases Dnmt3a and Dnmt3b (Doshi, Mehta, Dighe, Balasinor, & Vanage, 2011) and 
methyl binding proteins Mbd2 and Mbd4 (Tang et al., 2012).  
To date, few studies have investigated alterations to epigenetic marks across the genome 
following perinatal BPA exposure. Dhimolea et al. observed epigenome-wide alterations in DNA 
methylation in mammary tissue of 21-day-old Wistar-Furth rats exposed from gestational day 9 
to postnatal day 1 to 250 µg BPA/kg BW/day via subcutaneous osmotic pumps, although the 
majority of transcriptional changes did not occur until postnatal day 50 (2014). We reported 
dose-dependent regions of altered methylation in CpG island shores in liver tissue of wild-type 
(a/a) offspring of A
vy
 mice heterogeneous for the A
vy
 allele exposed perinatally to 50 µg or 50 mg 
BPA/kg maternal diet, and noted alterations in pathways associated with metabolism and 
stimulus response (Kim et al., 2014). However, to our knowledge, no study to date has utilized 
an epigenome-wide platform to assess pathway level changes associated with both BPA 
exposure and the presence of an adverse health effect later in life in rodents or humans. Here, we 
use an epigenome-wide tiling array platform, which together with gene set analysis, identified 
neuronal signaling and metabolism as de novo pathways linked to BPA exposure and hepatic 
tumorigenesis in mice. Additionally, we provide evidence supporting our a priori hypothesis that 
specific inflammatory signaling pathways would be linked to murine exposure and disease.  By 
mining human data curated in the Comparative Toxicogenomics Database, we deduce that BPA 
exposure has been linked to both neuronal and inflammatory signaling pathways described here, 
supporting the human health relevance of our experiments. The results provide a mechanistic 
hypothesis for how DNA methylation mediates the dose-dependent increase in hepatic tumors 
observed after perinatal BPA exposure.  
Materials and Methods 
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Mouse Liver Samples 
Mice were obtained from a colony generated by backcrossing C3H/HeJ mice carrying the 
viable yellow Agouti (A
vy
) allele with C57BL/6J mice, followed by >200 generations of sibling 
mating (Waterland & Jirtle, 2003). The A
vy
 strain is isogenic (Waterland & Jirtle, 2003) and has 
been empirically confirmed to be genetically 93% C57BL/6J (Weinhouse et al., 2014). As 
previously described (Anderson et al 2012b), virgin a/a dams, 6 weeks of age, were randomly 
assigned to one of four phytoestrogen-free AIN-93G diets (diet 95092 with 7% corn oil 
substituted for 7% soybean oil; Harlan Teklad, Madison, WI): (1) standard diet; (2) standard diet 
supplemented with 50 ng BPA/kg diet; (3) standard diet supplemented with 50 µg BPA/kg diet; 
(4) standard diet supplemented with 50 mg BPA/kg diet. All diet ingredients were supplied by 
Harlan Teklad except BPA, which was supplied by NTP (National Toxicology Program, Durham 
NC). Following 2 weeks on their respective diets, at 8 weeks of age a/a virgin dams were mated 
with A
vy
/a males, 7–8 weeks of age. All animals were housed in polycarbonate-free cages and 
provided ad libitum access to diet and BPA-free water. The dams remained on the assigned diets 
throughout pregnancy and lactation. This mating scheme produced approximately 50% wild-type 
(a/a) offspring and 50% heterozygous (A
vy
/a) offspring.  
The majority of A
vy
/a mice were euthanized on post-natal day (PND) 22 (Anderson et al., 
2012b). A subset of wild-type (a/a) mice (approximately 1 male and 1 female per litter for each 
BPA diet group) were then housed with a same-sex A
vy
/a sibling and fed the standard 
phytoestrogen-free control diet until they were euthanized at 10 months of age, as described by 
Anderson et al. (Anderson et al., 2013). During dissection, liver tissue was collected and flash 
frozen in liquid nitrogen, followed by evaluation for histopathologic lesions, including benign 
and malignant tumors, as previously described (Weinhouse et al., 2014). Liver tissue 
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measurements for free and conjugated (glucuronidated and sulfated) BPA in PND22 mouse liver 
samples (Anderson et al., 2012a) have confirmed liver BPA levels within the range of reported 
human environmental exposures (Vandenberg et al., 2012). 
In this study, we combined offspring in the 50 ng and 50 µg BPA dose groups into one 
“low BPA” group for comparison with offspring in the 50 mg BPA, or “high BPA” group (n=16 
offspring; n=4 male and n=4 female offspring exposed to “low BPA,” or 50 ng or 50 µg BPA/kg 
maternal diet; n=4 male and n=4 female offspring exposed to “high BPA,” or 50 mg BPA/kg 
maternal diet), as well as with wild-type a/a control mice (n=6 offspring; n=3 male and n=3 
female).We chose to combine offspring in the two lower dose groups for two reasons. First, the 
lower two dose groups combined presented with approximately the same number of tumors as 
the high dose group alone. An analysis that separated the animals into three dose groups would 
likely have been underpowered to detect meaningful differential methylation, due to small 
numbers of tumors in low dose groups. Second, this choice was biologically sound, as we have 
reported previously that internal liver tissue BPA levels from animals exposed to the two lower 
doses were very similar, but that liver tissue levels from animals exposed to the high BPA dose 
were 100-fold higher than the low dose groups (Anderson et al., 2012.) 
DNA Isolation  
Total genomic DNA was isolated from 10-month liver tissue (n=22) using a standard 
phenol-chloroform extraction method. Briefly, approximately 10-15 mg of liver tissue was 
homogenized for three 20-second pulses at 15 Hz (TissueLyser, Qiagen) in 540 µl of lysis buffer 
(buffer ATL, Qiagen) and incubated overnight at 50 ºC with 60 µl Proteinase K. Lysate was then 
incubated with 12 µl RNase A for 10 minutes at 37 ºC.  The DNA-containing aqueous phase was 
extracted twice with 600 µl phenol-chloroform-isoamyl alcohol, followed by a single extraction 
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with 600 µl chloroform, using Phase Gel Lock tubes (5 Prime, Gaithersburg, Maryland). 50 µl 
3M sodium acetate was added to decanted aqueous phase. DNA was precipitated once with 1 mL 
of 100% ethanol and twice with 1 mL of 75% ethanol. Pellets were air dried and resuspended in 
50 µl Tris-EDTA buffer during 2-hour incubation at 60 ºC with frequent mixing. 
DNA Fragmentation  
Genomic DNA was sheared to fragment sizes ranging from 200 to 1000 bp using 
manufacturer’s instructions on an Episonic 1100 series sonicator (Farmingdale, NY). Briefly, 17 
µg of DNA was divided into two volumes of 8.5 µg in separate PCR tubes and was sonicated in 
a polycarbonate plastic tube rack with a total process time of 15 minutes (15 second on and 30 
second off cycles, amplitude of 18) in 8-20 ºC water. Water was monitored and cooled with 
sonicator cooling system every 5 minutes of process time. Fragment sizes for each sample were 
confirmed with ~1 µg DNA via gel electrophoresis. One sonicated aliquot per sample was 
enriched for methylated DNA, as described below. Matching sample aliquots were reserved as 
genomic input for co-hybridization with enriched fractions to microarrays. 
Enrichment and Whole Genome Amplification of Methylated DNA  
Methylated DNA fragments from one sonication aliquot per sample were enriched for 
methylcytosine using methyl-CpG binding domain-based capture (MBD-Cap) with the EpiMark 
Methylated DNA Enrichment Kit (New England BioLabs, Ipswich, Massachusetts). The 
EpiMark kit uses a fusion protein (MBD-Fc) containing the highly conserved methyl binding 
domain (MBD) of human MBD2 protein fused to the Fc tail of human IgG. MBD-Fc proteins 
and paramagnetic protein A beads were incubated for 15 minutes at room temperature, allowing 
Fc domains to couple with protein A beads, and washed twice with wash buffer. Fragmented 
genomic DNA was added to MBD-Fc/bead mixture, rotated at room temperature for 20 minutes, 
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and washed three times with wash buffer to discard unbound DNA. Captured methylated DNA 
was eluted with 100 µl of DNase-free water during a 15-minute incubation at 65 ºC. Residual 
unmethylated DNA fractions were reserved for downstream enrichment testing via qPCR. In 
order to obtain sufficient DNA for microarray hybridization, 10 ng of captured methylated DNA 
was amplified using GenomePlex Complete Whole Genome Amplification Kit (Sigma-Aldrich, 
St. Louis, Missouri).  
Methylated DNA Enrichment Quality Assessment  
Quality assessment for methylated DNA enrichment was performed via qPCR of two 
methylated regions at Xist and H19 loci used as positive control probes on the microarray 
platform used in this study. Chromosomal coordinates of control probes were obtained directly 
from microarray manufacturers (Roche NimbleGen Inc., Madison, Wisconsin), and qPCR assays 
were designed to capture Xist and H19 positive control probe sequences. Approximately 60 ng 
each of genomic input sonicated DNA (diluted 1:10), unmethylated DNA from uncaptured 
fraction reserved after enrichment step (diluted 1:10), and WGA enriched DNA (diluted 1:100) 
was analyzed for relative enrichment of fragments containing control probe sequences. 
Quantitative PCR was performed in duplicate 25 µl reactions using SYBR Green Master Mix 
(Qiagen Inc., Valencia, California), 0.25 pmol forward and reverse primers, and 60 ng input 
DNA from above, under the following reaction conditions: 95 ºC for 3 minutes, followed by 39 
cycles of 10 seconds at 95 ºC, 62 ºC for 30 seconds, 72 ºC for 10 seconds, with a final 
incremental temperature decrease from 95 ºC for melt curve analysis to confirm product 
uniqueness. The average threshold cycle (C(t)) from duplicate reactions was calculated using 
CFX Manager Version1.6 software (Bio-Rad). A minimum of 10-fold enrichment of positive 
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control regions in methylated fraction over genomic fraction was confirmed for each sample 
prior to sample hybridization to microarrays. 
Hybridization and Array Scanning 
Experimental enriched and genomic input fractions for each sample were labeled with 
Cy5 and Cy3, respectively, with NimbleGen Dual-Color Labeling Kit (Roche NimbleGen, 
Madison, Wisconsin) following instructions in the NimbleGen Array User Guide (Nimblegen 
Array User Guide DNA Methylation Arrays, Version 7.2). Labeled fractions were pooled and co-
hybridized to Roche NimbleGen Mouse DNA Methylation 3x720K CpG Island Plus RefSeq 
Promoter Arrays for 16-20 hours. These promoter DNA methylation tiling arrays contain three 
subarrays, each containing 720,000 probes that scan 15,980 CpG islands in 20,404 murine gene 
promoters. Probe tiling ranges from 2,960 bp upstream to 740 bp downstream of transcription 
start sites. Probes range in length from 50-75 bp with median probe spacing of 100 bp. Following 
hybridization, arrays were washed and scanned using a 2 µm resolution NimbleGen MS 200 
Microarray Scanner (Dr. Thomas Glover, Department of Human Genetics, University of 
Michigan). All arrays were run by a single individual in two batches during January and March, 
months in which humidity and ozone levels were fairly consistently low. 
Bioinformatics Pipeline  
Array images were uploaded to NimbleGen DEVA software (version 2.3) and aligned 
using an automated alignment grid function. Raw signal intensities for each channel were 
exported using the software report function. Raw intensity values were background corrected 
using the norm+exp-offset method (to prevent loss of data that is common using background 
subtraction) and then quantile normalized across all samples. Quantile normalization was 
performed on untransformed intensity values. Following normalization, M values, or log2 ratios 
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of enriched sample signal intensity to input sample signal intensity, were computed for each 
feature on the array. Differentially enriched regions between dose and tumor groups were 
identified by comparing M values for each probe.  Regression models testing for differential 
methylation in gene promoters across the epigenome were run for four pair-wise comparisons: 1) 
animals with tumors (n=16; n=8 males and n=8 females) versus animals without tumors (n=6; 
n=3 males and n=3 females); 2) animals exposed to low BPA (n=8; n=4 males and n=4 females) 
versus control animals (n=6; n=3 males and n=3 females); 3) animals exposed to high BPA (n=8; 
n=4 males and n=4 females) versus control animals; and 4) animals exposed to high BPA versus 
low BPA. In this analysis, all animals exposed to BPA also presented with hepatic tumors; 
therefore, the tumor versus non-tumor comparison is equivalent to the low and high BPA groups 
together compared to the control group. The three pair-wise dose group comparisons were tested 
using binary dose variables (low BPA vs. control; high BPA vs. control; high BPA vs. low 
BPA), adjusting for sex and tumor status. The additional pair-wise comparison of tumor vs. non-
tumor samples was tested, adjusting for sex and dose. Linear regression models were fit using 
the lmFit function in the limma package in R.  Standard errors were moderated with an empirical 
Bayes model using the eBayes function in limma. The False Discovery Rate (FDR) was 
computed for multiple comparison testing using the Benjamini-Hochberg correction of the initial 
p-values. Array features were annotated using the mm9 genome assembly. Probes were analyzed 
individually, rather than aggregated into larger windows or collapsed by gene promoter, in order 
to retain high resolution of the tiling array platform and to detect region-specific changes that 
may be masked by analysis of larger, smoothed windows. All analyses were performed in R 
version 3.1.1 using R packages Ringo and limma. Array probes were considered differentially 
enriched at p<0.01 (Table 1).  
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Validation of Top Differentially Methylated Probes 
Quantitative DNA methylation patterns were analyzed via sodium bisulfite treatment 
followed by sequencing using Sequenom EpiTYPER MassARRAY technology in 5’ gene 
promoter regions containing differentially methylated probes with the lowest p-values (top hits) 
for each of four analysis comparisons (β = ratio of enriched to input signal): Lce1m (tumor vs. 
non-tumor; β=0.641, p=7.11E-6), Shmt2 (high BPA vs. low BPA; β=3.162, p=2.22E-7), Foxp2 
(low BPA vs. control; β=0.383, p=4.6E-6), and Ift46 (high BPA vs. control; β=3.181, p=2.17E-
5). Sodium bisulfite treatment was performed using the QIAGEN EpiTect Bisulfite Kit 
(QIAGEN) with approximately 1 µg input genomic DNA. EpiTYPER assays were designed 
using the Sequenom EpiDesigner tool (www.epidesigner.com), and top hit gene primer sets were 
assessed for unique products in the bisulfite-converted mouse and human genomes using the 
BiSearch ePCR tool (http://bisearch.enzim.hu). PCR was carried out in 25 µl reactions using 
approximately 50 ng of bisulfite-converted DNA, HotStarTaq master mix (QIAGEN Inc., 
Valencia, CA) and forward and reverse (0.1 pmol each) primers under the following conditions: 
15 minutes at 95ºC, 40 cycles of (30 seconds at 94ºC, 30 seconds at annealing temperature (TA), 
1 minute at 72ºC), 10 minutes at 72ºC.  The third most significant probe in the tumor vs. non-
tumor comparison was chosen for validation, because the first two did not contain CpG sites and 
were not within CpG islands, with adjacent regions of high CpG density. This DNA microarray 
includes some probe sequences that do not contain CpG sites but are located adjacent to CpG 
sitse; therefore, DNA fragments that contain methylated CpG sites adjacent to these probe 
sequences may be enriched during MBD-cap and identified as “differentially methylated.” 
Primer sequences for bisulfite sequencing of microarray top hits are listed in Table 2.   
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Dose- and tumor-dependent DNA methylation changes in 10-month mice with tumors, as 
compared to 10-month control mice without tumors, were assessed using repeated measures 
mixed models (PROC MIXED), with individual CpG sites defined as repeated measures, in 
order to account for lack of independence of multiple CpG sites at a single locus within an 
individual animal (Table 3).  One model was run per candidate gene, including four predictors: 
repeated CpG site, dichotomous tumor, dichotomous sex, and ordinal dose. Fixed effects of the 
dependent variable assessed associations between dose and tumor status with average 
methylation at a locus.  Dose was coded as an ordinal variable for all administered doses 
(control=0, 50 ng BPA/kg maternal diet=1, 50 µg BPA/kg maternal diet=2, and 50 mg BPA/kg 
maternal diet=3).  In order to directly validate microarray results, three contrast statements were 
included to closely mimic the comparisons in the regression models run on the microarray data 
(“low BPA,” or an average of effects of the two lowest doses, as compared to control; “high 
BPA,” or the highest dose, as compared to control, and “high BPA,” or the highest dose, as 
compared to “low BPA”, or an average of the effects of the two lowest doses). The tumor vs. 
non-tumor comparison was directly tested with a dichotomous tumor variable. All models 
contained a random intercept to cluster data by litter. In the model testing DNA methylation at 
Ift46 (4 CpG sites in the assay), an unstructured variance-covariance matrix was computed from 
the data (option type=un), in agreement with prior studies indicating site-specific basal 
methylation and lability. In models testing DNA methylation at Foxp2, Shmt2, and Lce1m, loci 
with large numbers of CpG sites, an unstructured variance-covariance matrix could not be 
computed and empirical standard errors were instead calculated (option empirical). All statistical 
analyses were performed in SAS v9.4 (Cary, NC). 
Pathway and GO Term Enrichment Analysis 
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Complete probe lists with p-values and β values (normalized ratios of enriched to input 
signal intensities) for each of four comparisons were uploaded to the LRpath web tool for 
pathway (BioCarta, KEGG, Panther, EHMN, and pFAM) and GO term (GO Biological 
Processes, GO Molecular Function, and GO Cellular Component) enrichment analyses. LRpath 
tests for gene sets with significantly higher significance values than expected at random using 
logistic regression, allowing data to remain on a continuous scale (Sartor et al., 2009).  
GO terms (Table 4) and pathway terms (Table 5) with FDR values <0.1 were first 
assessed for evidence of statistically significant changes in pathways or cellular processes linked 
to BPA exposure and HCC. A hypothesis-driven approach investigating the influence of Jak/Stat 
and Mapk signaling pathways was pursued, as well. First, all pathways related to Jak/Stat and 
Mapk signaling with p-values <0.05 in each of the above-mentioned four comparisons were 
identified. Unique mouse gene IDs in the selected pathways that were reported by LRpath as 
significant (average p-value <0.05 across probes for each gene) and were related to Jak/Stat (70 
mouse gene IDs) and Mapk (110 mouse gene IDs) across all four dose comparisons were 
annotated with gene names and descriptions using NCBI’s Batch Entrez tool 
(http://www.ncbi.nlm.nih.gov/sites/batchentrez). To assess the relevance of these results to the 
human pathway response to BPA exposure, genes within human JAK/STAT (61 human gene 
IDs) and MAPK (177 human gene IDs) signaling pathways known to be altered by BPA were 
downloaded from The Comparative Toxicogenomics Database (CTD; http://ctdbase.org/) and 
compared to the mouse gene IDs. The gene overlaps in these pathways are listed in 
Supplementary Tables S3 and S4 and shown visually in Figures 1 and 2. Gene set overlaps 
were overlaid onto KEGG pathways using the KEGG Pathway Mapper tool 
(http://www.genome.jp/kegg/pathway.html). 
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 Of the four comparisons, the largest number of changes were observed for tumor vs. non-
tumor animals (12,822 probes with p<0.01), followed by high BPA vs. control, high BPA vs. 
low BPA, and, with the fewest probes, low BPA vs. control (Table 1). In most comparisons, 
roughly two-thirds of differentially methylated probes were hypomethylated and one-third were 
hypermethylated, with the exception of the high BPA vs. low BPA comparison, in which the 
pattern was reversed (Table 1). 
Validation of Top Differentially Methylated Probes 
 Technical validation of the microarray platform used in this study was performed via 
bisulfite sequencing of 5’ gene promoter regions containing differentially methylated probes 
with the lowest p-values (top hits) for each of four analysis comparisons (Tables 2 and 3.) 
Foxp2, Ift46, and Shmt2 displayed differential methylation (p<0.05) on bisulfite sequencing in at 
least one of four comparisons (Table 3). However, differential methylation on microarray was 
not consistently observed in the same tumor or dose comparison in bisulfite sequencing results 
(Table 3). These results indicate that microarray data are valid and meaningful, but that results 
should be interpreted broadly across comparisons tested.  
Gene Ontology Term Enrichment 
Since few individual probes displayed significant altered methylation by dose group or 
tumor status following FDR correction for multiple testing, we opted to test for groups of genes 
significantly enriched with differential methylation using Gene Ontology (GO), which can 
greatly increase the power to detect significant changes or trends (Ashburner et al., 2000).  
Thirty-three GO terms were enriched with differential methylation for animals with tumors 
versus without tumors (FDR<0.1) (Table 4a, full significant gene lists in Supplemental Table 
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S1). Genes in all 33 of the significant biological processes were hypermethylated, except two: 
positive regulation of cell matrix adhesion (p=5.1E-5, FDR=0.05) and regulation of the force of 
heart contraction (p=0.00072, FDR=0.064). The majority of these terms (n=27) were involved in 
morphogenesis or development (including hepaticobiliary system development, p=1.0E-5, 
FDR=0.0035; and organ morphogenesis, p=4.0E-4, FDR=0.05). The most significant GO term 
was middle ear morphogenesis, which contained 5 genes (out of 11) with a change in 
methylation and demonstrated a hypermethylation pattern (p=1.9E-8, FDR=4.6E-5). These five 
genes appeared 10 or 11 times each associated with the 33 GO terms on this list, indicating a 
high degree of overlap in these processes. Six GO terms related to epigenomic alteration 
displayed promoter hypermethylation in this comparison (demethylation, p=0.00019, FDR=0.03; 
histone modification, p=2.9E-4, FDR=0.040; covalent chromatin modification, p=2.46E-4, 
FDR=0.04; positive regulation of DNA repair, p=3.7E-4, FDR=0.05; and one-carbon metabolic 
process, p=0.0017, FDR=0.11).  Demethylation contained eight genes, including CYP450 
enzymes Cyp3a11, Cyp3a16, Cyp3a44, and three lysine-specific demethylases. One-carbon 
metabolic process contained 31 genes, including mitochondrial serine hydroxymethyltransferase 
2 (Shmt2) and methionine adenosyltransferase I α (Mat1a), which catalyzes the biosynthesis of 
methyl donor S-adenosylmethionine (Rountree et al., 2008).  
Four GO terms were significant in the low BPA vs. control comparison (Table 4b, full 
significant gene lists in Supplemental Table S1). Three terms that refer primarily to cellular 
transport were hypermethylated, including Golgi to plasma membrane transport (p=1.2E-5, 
FDR=0.03); macromolecule transmembrane transporter activity (p=1.4E-4, FDR=0.04); and 
protein transmembrane transporter activity (p=1.4E-4, FDR=0.04). The remaining term, NADP 
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or NADPH binding (p=5.3E-4, FDR=0.099), was hypomethylated, and may be broadly related to 
the redox state of the cells investigated.  
The high BPA vs. control comparison showed seven significant GO terms (Table 4b, full 
significant gene lists in Supplemental Table S1), including two terms related to transcription 
factor binding to DNA (sequence specific DNA binding, p=1.5E-4, FDR=0.04; sequence specific 
DNA binding transcription factor activity, p=2.6E-4, FDR=0.05) and two related to activity of 
ligases that form carbon-sulfur bonds (acid-thiol ligase activity, p=5.1E-5, FDR=0.03, ligase 
activity, forming carbon-sulfur bonds, p=4.02E-4, FDR=0.06). The remaining three terms refer 
to membrane-bound proteins (extrinsic to membrane, p=3.15E-5, FDR=0.0061; heterotrimeric 
G-protein complex, p=3.27E-5, FDR=0.006; extrinsic to plasma membrane, p=3.2E-4, 
FDR=0.04). The remaining comparison, high BPA vs. low BPA, showed the same seven 
significant GO terms listed above for the high BPA vs. control comparison (Table 4b, full 
significant gene lists in Supplemental Table S1). 
Pathway Enrichment 
Testing for pathways enriched with differential methylation revealed a predominance of 
hypermethylated neuronal signaling pathways in the high BPA vs. control comparison, including 
histamine H1 and H2 receptor mediated signaling, 5HT1 and 5HT4 serotonin receptor mediated 
signaling pathways, β1, β2, and β3 adrenergic receptor signaling pathways, thyrotropin-releasing 
hormone receptor signaling, GABA and glutamate receptor signaling, and muscarinic 
acetylcholine receptor 1, 2, 3 and 4 signaling (Table 5, full significant gene lists in 
Supplemental Table S2). Non-neuronal pathways significant in the high BPA vs. control 
comparison include Erk signaling (role of Erk5 in neuronal survival, p=1.8E-4, FDR=0.03) and 
PI3K signaling (PI3 kinase pathway, p=0.010, FDR=0.05) pathways (Table 5, full significant 
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gene lists in Supplemental Table S2). Two pathway terms were significant in the low BPA vs. 
control comparison, including selenocompound metabolism (p=1.3E-5, FDR=0.003), which may 
be linked to cellular redox state (Table 5, full significant gene lists in Supplemental Table S2). 
In addition to our agnostic assessment of altered biological pathways, we further 
analyzed the data using a hypothesis-driven approach for relevance to human exposure to BPA 
and to the HCC phenotype under study. We hypothesized that Jak/Stat and Mapk signaling 
pathways would be altered in a tumor status- and dose-dependent manner. Jak/Stat and Mapk 
signaling have previously been implicated in the literature in mediating estrogen-dependent 
protection of females from hepatocellular carcinoma (Sekine et al., 2004, Shi et al., 2014a). 
Hypothesis-driven analysis (see methods for details) revealed 70 differentially methylated mouse 
genes in the selected concepts related to Jak/Stat and 110 differentially methylated genes related 
to Mapk across all four dose comparisons. Sixty-one genes within the human JAK/STAT 
pathways and 177 genes within human MAPK signaling pathways with prior evidence of 
response to BPA were compared to the 70 and 110 mouse gene lists. Mouse microarray results 
overlapped with human homologs with known interactions with BPA at 10 genes in JAK/STAT 
signaling (Figure 1, Supplemental Table S3), including the kinase JAK1 and the transcription 
factors STAT5A and STAT5B, and at 32 genes in MAPK signaling (Figure 2, Supplemental 
Table S4), including the oncogene MYC and ten members of the mitogen-activated kinase (MAP 
kinase) family.  
Discussion  
In the present study, we used epigenome-wide microarrays to detect differential DNA 
methylation in 5’ gene promoters in liver tumor tissue of 10-month-old isogenic mice that were 
transiently exposed to BPA during gestation and lactation. Although we did not identify many 
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individual probes with FDR<0.1, gene set enrichment testing detected subtle but consistent 
changes across GO terms and pathways. Furthermore, these data indicate patterns of change that 
suggest specific biological responses and provide direction for future work.  
We identified several processes with altered epigenetic patterning across the genome, 
supporting the hypothesis of large scale, yet subtle, epigenomic change in mice following BPA 
exposure. Animals with liver tumors showed enrichment for genes in one-carbon metabolic 
process as compared to animals without liver tumors. This GO term included mitochondrial 
serine hydroxymethyltransferase 2 (Shmt2) and methionine adenosyltransferase I α (Mat1a), 
which are linked not only to regulation of epigenetic patterning but also to liver function and 
pathology (Liu et al., 2007; Rountree et al., 2008). Morphogenic and developmental processes, 
which were hypermethylated in mice with tumors as compared to mice without tumors, may be 
altered due to cancer-related pathway reversion to embryonic states (Hanahan and Weinberg, 
2011) or to a relative increase in the proportion of stem cells in liver tissue, suggested by a dose-
dependent increase in oval cell hyperplasia noted in mice with hepatic tumors (Weinhouse et al., 
2014). 
Agnostic pathway analysis revealed a predominance of hypermethylated neuronal 
pathways linked to energy regulation and metabolic function, suggesting that BPA-induced 
disruption of neuronal signaling pathways may have metabolic consequences in the liver. 
Histamine receptor signaling plays a role in the development of hyperlipidemia-induced non-
alcoholic steatohepatitis (NASH) (Wang et al., 2010). Histamine (Knigge et al., 1984) and 
serotonin (Castrogiovanni et al., 2014) also regulate growth hormone secretion and IGF-1 
production. β-adrenergic receptor signaling has been reported to drive lipolysis in adipose tissue 
(Thompson et al., 2014), suggesting that pathway suppression is consistent with steatosis 
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previously reported in study animals (Weinhouse et al., 2014). Metabolic dysfunction has been 
associated with both exposure to environmental estrogens and liver disease states. Elevated IGF-
1 is a risk factor for HCC development, possibly due to altered metabolism secondary to liver 
damage (Lukanova et al., 2014).  Type II diabetes confers a 2.3 fold increase in risk for HCC, 
regardless of other risk factors, including cirrhosis (Lukanova et al., 2014). Some hormonal 
contraceptives have been linked to altered metabolism, as well. Depot medroxyprogesterone 
acetate increased glucose and insulin levels in the first 18-30 months of use (Berenson et al., 
2011), and African-American women using oral contraceptives were more insulin resistant than 
controls (Frempong et al., 2008). This may be relevant, because hepatic adenomas (HA), a rare 
form of benign liver tumor historically associated nearly exclusively with long term use of high 
dose oral contraceptives, have been increasingly linked to hormonal or metabolic imbalances that 
stimulate hepatocyte proliferation (Farges & Dokmak, 2010; González-Lara, et al., 2013).  
Suppression of neuronal pathways as suggested by the observed promoter DNA 
hypermethylation response may allow for higher tissue levels of Igf1 and increased proliferative 
response in the liver. However, these results should be interpreted with caution, as none of the 19 
pathway terms related to IGF signaling, insulin signaling, or growth hormone signaling were 
statistically enriched for in these analyses. In addition, neuronal signaling pathways identified 
here may be related to phenotypic effects of BPA exposure other than liver tumors. Perinatal 
BPA exposure has been linked to hyperactivity and anxiety (Anderson et al., 2013) as well as 
decreased hippocampal serotonin signaling (Texel et al., 2012). 
 In addition to our agnostic results, we took a hypothesis-driven approach. The classical 
sexual dimorphism in incidence not seen in our study is well accepted to result from a 
suppression of IL-6 production by endogenous estradiol and downstream suppression of STAT3 
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signaling (Sekine et al., 2004). As Jak/Stat and Mapk signaling pathways have previously been 
implicated in male: female dimorphism in incidence, we investigated a potential link between 
these pathways and hepatic tumors in BPA-exposed mice. We report an overlap of genes 
implicated in Jak/STAT and MAPK signaling with altered 5’ promoter methylation in mice 
perinatally exposed to BPA presenting with hepatic tumors, with genes linked to the same 
pathways noted to respond to human BPA exposure in The Comparative Toxicogenomics 
Database (Davis et al., 2014). Three key overlapping genes, Jak1, Stat5b, and Akt1, have 
previously characterized roles linked to liver carcinogenesis. JAK1 activation mediates PI3K and 
Akt phosphorylation and contributes to downstream inflammation in immortalized human HSC 
(LX-2) cells and in human HCC (HepG2) cells (Niu et al., 2007). STAT5b activation is 
associated with epithelial-to-mesenchymal transition in human clinical HCC samples, and is 
linked to younger age of onset and advanced tumor stages (Lee et al., 2006). STAT5b is also 
required for sexually dimorphic liver gene expression (Udy et al., 1997).   
In summary, these results indicate that BPA may lead to liver carcinogenesis and 
metabolic dysfunction via alterations in neuronal signaling pathways. In addition, our results 
identified specific genes within Jak/Stat and Mapk signaling pathways that may mediate the link 
between early life BPA exposure and later life hepatic tumors in mice. We compared 
differentially methylated gene lists from our rodent BPA study with prior data on genes 
associated with human BPA exposure, rather than with hepatic tumors. This approach allowed us 
to distinguish genes that are potential early causal factors in tumorigenesis linked to BPA 
exposure from genes associated with the highly dysregulated biology of tumor tissue that might 
be common to many tumors unrelated to BPA exposure.  However, these data must be 
interpreted in the context of limitations of experimental design. First, DNA samples for 
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microarray experiments were extracted from liver tumor tissue. Epithelial liver tumors are 
primarily composed of hepatocytes, but may also contain vascular, nervous, and fat tissue. Thus, 
we cannot rule out that differences in percent DNA methylation may be due wholly or in part to 
differences in relative proportions of cell types within tissue samples. Second, further 
experiments are needed to fully characterize how identified pathways act in the context of our 
observed liver tumor phenotype. Future studies that include observation of animals at earlier time 
points prior to tumor development would clarify temporality of inflammation and its potential 
link with perinatal BPA exposure. Third, in this study, we did not test whether expression of 
identified genes was regulated by DNA methylation. Experimental assessment of a regulatory 
role for DN  methylation in expression change is complicated by several factors. DNA 
methylation may be temporally unlinked from expression change; that is, DNA methylation 
changes may represent markers of concurrent expression change, but they may also represent 
residual markers of prior expression change or markers of expression change “risk”, or priming 
for a future response.  Therefore, a large number of experimental time points would be required 
to fully test this question. In addition, in order to assess a causal regulatory role for DNA 
methylation changes, experimental tools for inducing targeted and precise DNA methylation 
change would be required. These tools are under development but are not yet widely or easily 
available, nor do they provide unambiguous answers.  
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Table 1. Microarray probes exhibiting differential methylation (p<0.01) by BPA dose and tumor status. 
Comparison Total probes  
N (% of array probes) 
Hypermethylated probes  
N (% of total differential 
probes) 
Hypomethylated probes 
N (% of total differential 
probes) 
Tumor vs. non-tumor 12,822 (1.8) 4,166 (32.5) 8,656 (67.5) 
High BPA vs. control 9,649 (1.3) 3,182 (33) 6,467 (67) 
Low BPA vs. control 3,752 (0.52) 1,510 (40.2) 2,242 (59.8) 
High BPA vs. low BPA 7,308 (1.0) 4,763 (65.2) 2,545 (34.8) 
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Table 2. Primer sets for bisulfite sequencing 
Assay Forward Primer Reverse Primer Product Size TA 
#CpG 
sites 
Lce1m 5’-TTAGATTGTTGATGGTTGTTGTTGT-3’ 5’-AATACCCTCCAACCTCTTCCTACTA-3’ 457 bp 57ºC 14 
Shmt2 5’-TTGGGTGATTATAAGATTTTATTTAGG-3’ 5’-AAAACTTTTCAAACAAAACTCTCCA-3’ 484 bp 57ºC 16 
Foxp2 5’-ATTTTGGGGATTGTTAAGAAGTAGT-3’ 5’-CCCAACTTTTTCCAAAAATAAAAAA-3’ 487 bp 54ºC 8 
Ift46 5’-TGTTTTTGGGTTAGGAAATTTTTTT-3’ 5’-TCTCATCTTCTCTTACCTTACTATCCTAAA-3’ 236 bp 48ºC 4 
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Table 3. Microarray validation using bisulfite sequencing 
  Microarray  Bisulfite sequencing validation 
Gene Comparison β coefficient* P-value Comparison β coefficient** P-value 
Lce1m 
Tumor vs. Non-
tumor 0.64 7.10E-06 Tumor vs. Non-tumor 0.010 0.77 
    Low vs. Control 0.018 0.85 
    High vs. Control 0.024 0.64 
    High vs. Low 0.0060 0.39 
              
Foxp2 Low vs. Control 0.38 4.60E-06 Tumor vs. Non-tumor -0.0089 0.015 
    Low vs. Control -0.0059 0.59 
    High vs. Control 0.0074 0.081 
    High vs. Low 0.013 0.14 
              
Ift46 High vs. Control 3.2 2.20E-05 Tumor vs. Non-tumor -0.0048 0.61 
    Low vs. Control 0.027 0.018 
    High vs. Control 0.010 0.075 
    High vs. Low -0.017 0.42 
              
Shmt2 High vs. Low 3.2 2.20E-07 Tumor vs. Non-tumor 0.00090 0.73 
    Low vs. Control -0.019 0.0028 
    High vs. Control -0.0056 0.073 
    High vs. Low 0.013 0.26 
*Microarray β coefficients are intensity ratios of enriched: input. Ratios <1 indicate hypomethylation; ratios >1 indicate hypermethylation. 
**Bisulfite sequencing β coefficients are derived from regression models. Coefficients <0 indicate hypomethyaltion; coefficients >0 indicate hypermethylation. 
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Table 4a.  GO terms significantly enriched with differential methylation by tumor status. 
Name Comparison #Genes P-Value FDR Direction 
middle ear morphogenesis Tumor vs. No tumor 11 1.87E-08 4.64E-05 up 
ear morphogenesis Tumor vs. No tumor 51 8.84E-08 1.10E-04 up 
embryonic organ morphogenesis Tumor vs. No tumor 95 2.03E-07 1.68E-04 up 
ear development Tumor vs. No tumor 66 1.40E-06 8.69E-04 up 
sensory organ development Tumor vs. No tumor 169 2.20E-06 0.001091 up 
embryonic organ development Tumor vs. No tumor 142 6.39E-06 0.002641 up 
hepaticobiliary system development Tumor vs. No tumor 50 1.03E-05 0.003484 up 
liver development Tumor vs. No tumor 49 1.12E-05 0.003484 up 
chordate embryonic development Tumor vs. No tumor 248 4.52E-05 0.01126 up 
embryo development ending in birth or egg 
hatching 
Tumor vs. No tumor 250 4.54E-05 0.01126 up 
inner ear morphogenesis Tumor vs. No tumor 41 6.34E-05 0.014279 up 
kidney development Tumor vs. No tumor 62 1.58E-04 0.03268 up 
brain development Tumor vs. No tumor 205 1.76E-04 0.033418 up 
demethylation Tumor vs. No tumor 14 1.94E-04 0.033418 up 
renal system development Tumor vs. No tumor 65 2.02E-04 0.033418 up 
covalent chromatin modification Tumor vs. No tumor 116 2.46E-04 0.038055 up 
metanephros development Tumor vs. No tumor 21 2.65E-04 0.038651 up 
histone modification Tumor vs. No tumor 113 2.88E-04 0.039684 up 
positive regulation of DNA repair Tumor vs. No tumor 13 3.66E-04 0.046376 up 
multicellular organism growth Tumor vs. No tumor 44 3.77E-04 0.046376 up 
organ morphogenesis Tumor vs. No tumor 434 3.93E-04 0.046376 up 
organ growth Tumor vs. No tumor 40 4.12E-04 0.046376 up 
positive regulation of cell-matrix adhesion Tumor vs. No tumor 14 5.06E-04 0.054574 down 
camera-type eye development Tumor vs. No tumor 77 5.80E-04 0.059948 up 
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double-strand break repair Tumor vs. No tumor 44 6.21E-04 0.061604 up 
urogenital system development Tumor vs. No tumor 91 7.21E-04 0.06416 up 
regulation of the force of heart contraction Tumor vs. No tumor 11 7.23E-04 0.06416 down 
palate development Tumor vs. No tumor 29 7.27E-04 0.06416 up 
central nervous system neuron 
development 
Tumor vs. No tumor 18 7.51E-04 0.06416 up 
histone demethylase activity Tumor vs. No tumor 10 9.82E-05 0.039075 up 
demethylase activity Tumor vs. No tumor 13 1.39E-04 0.039075 up 
specific transcriptional repressor activity Tumor vs. No tumor 26 5.12E-04 0.07352 up 
protein methyltransferase activity Tumor vs. No tumor 38 5.23E-04 0.07352 up 
 
Table 4b.  GO terms significantly enriched with differential methylation by BPA exposure level. 
Name Comparison #Genes P-Value FDR Direction 
Golgi to plasma membrane transport Low BPA vs. Control 10 1.23E-05 0.030447 up 
macromolecule transmembrane transporter 
activity 
Low BPA vs. Control 10 1.45E-04 0.040759 up 
protein transmembrane transporter activity Low BPA vs. Control 10 1.45E-04 0.040759 up 
NADP or NADPH binding Low BPA vs. Control 26 5.28E-04 0.098975 down 
extrinsic to membrane High BPA vs. Control 47 3.15E-05 0.006091 up 
heterotrimeric G-protein complex High BPA vs. Control 10 3.27E-05 0.006091 up 
extrinsic to plasma membrane High BPA vs. Control 26 3.25E-04 0.040366 up 
acid-thiol ligase activity High BPA vs. Control 13 5.11E-05 0.028725 up 
sequence-specific DNA binding High BPA vs. Control 424 1.53E-04 0.043107 up 
sequence-specific DNA binding 
transcription factor activity 
High BPA vs. Control 614 2.56E-04 0.04804 up 
ligase activity, forming carbon-sulfur High BPA vs. Control 22 4.02E-04 0.056521 up 
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extrinsic to membrane High BPA vs. Low BPA 47 3.15E-05 0.006091 up 
heterotrimeric G-protein complex High BPA vs. Low BPA 10 3.27E-05 0.006091 up 
extrinsic to plasma membrane High BPA vs. Low BPA 26 3.25E-04 0.040366 up 
acid-thiol ligase activity High BPA vs. Low BPA 13 5.11E-05 0.028725 up 
sequence-specific DNA binding High BPA vs. Low BPA 424 1.53E-04 0.043107 up 
sequence-specific DNA binding 
transcription factor activity 
High BPA vs. Low BPA 614 2.56E-04 0.04804 up 
ligase activity, forming carbon-sulfur 
bonds 
High BPA vs. Low BPA 22 4.02E-04 0.056521 up 
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Table 5. Pathway terms significantly enriched with differential methylation in BPA-exposed mice and/or with hepatic 
tumors  
Name Comparison #Genes P-Value FDR Direction 
Acute Myocardial Infarction Tumor vs. No tumor 14 6.24E-04 0.093603 up 
Selenocompound metabolism Low BPA vs. Control 13 1.28E-05 0.00258 up 
African trypanosomiasis Low BPA vs. Control 19 9.75E-04 0.098459 down 
Role of Erk5 in Neuronal Survival High BPA vs. Control 10 1.76E-04 0.026328 up 
Histamine H2 receptor mediated signaling pathway High BPA vs. Control 12 0.002505 0.039036 up 
Beta3 adrenergic receptor signaling pathway High BPA vs. Control 15 0.002672 0.039036 up 
5HT4 type receptor mediated signaling pathway High BPA vs. Control 16 0.002882 0.039036 up 
Endogenous cannabinoid signaling High BPA vs. Control 13 0.002974 0.039036 up 
Cortocotropin releasing factor receptor signaling 
pathway 
High BPA vs. Control 17 0.002982 0.039036 up 
Heterotrimeric G-protein signaling pathway-rod 
outer segment phototransduction 
High BPA vs. Control 19 0.003299 0.039036 up 
5HT1 type receptor mediated signaling pathway High BPA vs. Control 20 0.004139 0.039036 up 
Beta1 adrenergic receptor signaling pathway High BPA vs. Control 23 0.004662 0.039036 up 
Beta2 adrenergic receptor signaling pathway High BPA vs. Control 24 0.005096 0.039036 up 
GABA-B receptor II signaling High BPA vs. Control 18 0.005347 0.039036 up 
Metabotropic glutamate receptor group II pathway High BPA vs. Control 27 0.008168 0.047157 up 
Histamine H1 receptor mediated signaling pathway High BPA vs. Control 27 0.008371 0.047157 up 
Oxytocin receptor mediated signaling pathway High BPA vs. Control 35 0.009135 0.047157 up 
Muscarinic acetylcholine receptor 1 and 3 signaling 
pathway 
High BPA vs. Control 34 0.010031 0.047157 up 
Metabotropic glutamate receptor group III pathway High BPA vs. Control 39 0.010058 0.047157 up 
PI3 kinase pathway High BPA vs. Control 30 0.010336 0.047157 up 
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Figure 1. Overlapping mouse and human genes altered by BPA exposure in the Jak-Stat signaling pathway Unique mouse microarray gene IDs involved 
in Jak/Stat signaling that overlap with human JAK/STAT gene IDs with known interactions with BPA in The Comparative Toxicogenomics Database are 
shown in red. 
 
Figure 2. Overlapping mouse and human genes altered by BPA exposure in the Mapk signaling pathway. Unique mouse microarray gene IDs involved in 










5HT2 type receptor mediated signaling pathway High BPA vs. Control 37 0.011884 0.04919 up 
Thyrotropin-releasing hormone receptor signaling 
pathway 
High BPA vs. Control 36 0.012129 0.04919 up 
Muscarinic acetylcholine receptor 2 and 4 signaling 
pathway 
High BPA vs. Control 34 0.014209 0.054593 up 
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Figure 1. Overlapping mouse and human genes altered by BPA exposure in the Jak-Stat signaling pathway 
Unique mouse microarray gene IDs involved in Jak/Stat signaling that overlap with human JAK/STAT gene 
IDs with known interactions with BPA in The Comparative Toxicogenomics Database are shown in red.  
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Figure 2. Overlapping mouse and human genes altered by BPA exposure in the Mapk signaling pathway. 
Unique mouse microarray gene IDs involved in Mapk signaling that overlap with human MAPK gene IDs with 
known interactions with BPA in The Comparative Toxicogenomics Database are shown in red.  
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